Cargando…

Novel CCL21-Vault Nanocapsule Intratumoral Delivery Inhibits Lung Cancer Growth

BACKGROUND: Based on our preclinical findings, we are assessing the efficacy of intratumoral injection of dendritic cells (DC) transduced with an adenoviral vector expressing the secondary lymphoid chemokine (CCL21) gene (Ad-CCL21-DC) in a phase I trial in advanced non-small cell lung cancer (NSCLC)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kar, Upendra K., Srivastava, Minu K., Andersson, Åsa, Baratelli, Felicita, Huang, Min, Kickhoefer, Valerie A., Dubinett, Steven M., Rome, Leonard H., Sharma, Sherven
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086906/ https://www.ncbi.nlm.nih.gov/pubmed/21559281 http://dx.doi.org/10.1371/journal.pone.0018758

Ejemplares similares

Vault Nanocapsules as Adjuvants Favor Cell-Mediated over Antibody-Mediated Immune Responses following Immunization of Mice
por: Kar, Upendra K., et al.
Publicado: (2012)

Overexpression of CCL-21/Secondary Lymphoid Tissue Chemokine in Human Dendritic Cells Augments Chemotactic Activities for Lymphocytes and Antigen Presenting Cells
por: Riedl, Karen, et al.
Publicado: (2003)

The p80 homology region of TEP1 is sufficient for its association with the telomerase and vault RNAs, and the vault particle
por: Poderycki, Michael J., et al.
Publicado: (2005)

Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in Non-Small Cell Lung Cancer
por: Baratelli, Felicita, et al.
Publicado: (2008)

The Telomerase/Vault-Associated Protein Tep1 Is Required for Vault RNA Stability and Its Association with the Vault Particle
por: Kickhoefer, Valerie A., et al.
Publicado: (2001)

Draft Crystal Structure of the Vault Shell at 9-Å Resolution
por: Anderson, Daniel H, et al.
Publicado: (2007)

PD-L1 expression correlates with immune response in a Phase I trial of CCL21 gene modified dendritic cell therapy in lung cancer
por: Lee, Jay M, et al.
Publicado: (2014)

Targeting MDSCs enhance therapeutic vaccination responses against lung cancer
por: Srivastava, Minu K., et al.
Publicado: (2012)

Polyribosomes Are Molecular 3D Nanoprinters That Orchestrate the Assembly of Vault Particles
por: Mrazek, Jan, et al.
Publicado: (2014)

IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer
por: Kachroo, Puja, et al.
Publicado: (2013)

Modulation of the Vault Protein-Protein Interaction for Tuning of Molecular Release
por: Yu, Kang, et al.
Publicado: (2017)

The 193-Kd Vault Protein, Vparp, Is a Novel Poly(Adp-Ribose) Polymerase
por: Kickhoefer, Valerie A., et al.
Publicado: (1999)

The TROVE module: A common element in Telomerase, Ro and Vault ribonucleoproteins
por: Bateman, Alex, et al.
Publicado: (2003)

CCL21 Cancer Immunotherapy
por: Lin, Yuan, et al.
Publicado: (2014)

A Protective Vaccine against Chlamydia Genital Infection Using Vault Nanoparticles without an Added Adjuvant
por: Jiang, Janina, et al.
Publicado: (2017)

A Vault Nanoparticle Vaccine Induces Protective Mucosal Immunity
por: Champion, Cheryl I., et al.
Publicado: (2009)

Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer
por: Srivastava, Minu K., et al.
Publicado: (2012)

Correction: Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer
por: Srivastava, Minu K., et al.
Publicado: (2012)

Bioengineered Vaults: Self-Assembling Protein Shell–Lipophilic Core Nanoparticles for Drug Delivery
por: Buehler, Daniel C., et al.
Publicado: (2014)

SLC/CCL21-mediated anti-tumor responses require IFNγ, MIG/CXCL9 and IP-10/CXCL10
por: Sharma, Sherven, et al.
Publicado: (2003)

Polymeric nanocapsules: An emerging drug delivery system
por: Nagaich, Upendra
Publicado: (2018)

Recombinant Major Vault Protein Is Targeted to Neuritic Tips of PC12 Cells
por: Herrmann, Christine, et al.
Publicado: (1999)

Technical Feasibility and Safety of Repeated Computed Tomography–Guided Transthoracic Intratumoral Injection of Gene-Modified Cellular Immunotherapy in Metastatic NSCLC
por: Shahrouki, Puja, et al.
Publicado: (2021)

Immunoediting role for major vault protein in apoptotic signaling induced by bacterial N-acyl homoserine lactones
por: Rayo, Josep, et al.
Publicado: (2021)

Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer
por: Srivastava, Minu K, et al.
Publicado: (2012)

The Malignant Pleural Effusion as a Model to Investigate Intratumoral Heterogeneity in Lung Cancer
por: Basak, Saroj K., et al.
Publicado: (2009)

Vaginal Vault Prolapse
por: Uzoma, Azubuike, et al.
Publicado: (2009)

Differential ligand-signaling network of CCL19/CCL21-CCR7 system
por: Raju, Rajesh, et al.
Publicado: (2015)

Privies and Vaults
Publicado: (1875)

Privy Vaults
Publicado: (1875)

CCL19 reduces tumour burden in a model of advanced lung cancer
por: Hillinger, S, et al.
Publicado: (2006)

CCL5-deficiency enhances intratumoral infiltration of CD8(+) T cells in colorectal cancer
por: Zhang, Shengbo, et al.
Publicado: (2018)

CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions
por: Akhavanpoor, Mohammadreza, et al.
Publicado: (2014)

Ewing's Sarcoma of the Cranial Vault
por: Narayanan, Geetha, et al.
Publicado: (2016)

The Role of PPARγ in the Cyclooxygenase Pathway in Lung Cancer
por: Hazra, Saswati, et al.
Publicado: (2008)

Mediaeval church vaulting /
por: Ward, Clarence, 1884-
Publicado: (1915)

Cavern UX - vault
por: Valeriane Duvivier
Publicado: (2002)

Vault cavern UX
por: Valeriane Duvivier
Publicado: (2001)

vault cavern UX
por: Valeriane Duvivier
Publicado: (2001)

Concreting the SPS vault
Publicado: (1974)

Cannot write session to /tmp/vufind_sessions/sess_9gvntqqrbliu429673is9prtbt